Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Providers
Hospitals
Practices
Retail
Health Tech
AI and Machine Learning
Digital Health
Telehealth
Payers
Regulatory
Finance
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Webinars
Fierce Events
Industry Events
Podcasts
Survey
Whitepapers
Events
Subscribe
Subscribe
Providers
Hospitals
Practices
Retail
Health Tech
AI and Machine Learning
Digital Health
Telehealth
Payers
Regulatory
Finance
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Webinars
Fierce Events
Industry Events
Podcasts
Survey
Whitepapers
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Boehringer Ingelheim
Providers
HRSA calls for Boehringer Ingelheim to be fined for 340B moves
HRSA is pushing for Boehringer Ingelheim to be fined for its decision to cut off sales of 340B-discounted products to contract pharmacies.
Robert King
Mar 31, 2022 7:10am
Report: Outcome Health misled advertisers by inflating data
Oct 12, 2017 5:24pm
Value of EHR timestamp data; patient data ownership—roundup
Sep 29, 2017 1:10pm
Many COPD patients struggle to pay for each medicinal breath
Jun 5, 2017 4:05pm